ATYR SCHEDULE 13G/A: SEC filing
Federated Hermes, Inc. and affiliated entities
Filed with the SEC on · accession 0001623632-26-001548
ATYR filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 7, 2026. Federated Hermes, Inc. and affiliated entities filed an amended Schedule 13G disclosing their beneficial ownership position in aTyr Pharma, Inc. as passive investors. The stock moved -1.8% by the first close after the filing.
Summary of the filing
Federated Hermes, Inc. and affiliated entities filed an amended Schedule 13G disclosing their beneficial ownership position in aTyr Pharma, Inc. as passive investors. The filing identifies the reporting persons as investment advisers, parent holding companies, and trustees, who disclaim beneficial ownership beyond their advisory roles.
Key details
How ATYR stock reacted
Close before
$11.34
Oct 6, 2026
First close after
-1.80%
$11.13
5 trading days
-29.04%
$8.04
Since filing
-43.98%
$6.35
✦ Ask GOAX AI about this filing — what it means for ATYR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ATYR?
Click hereFrequently asked questions
What did ATYR file with the SEC on Oct 7, 2026?
ATYR filed a SCHEDULE 13G/A (SEC filing). Federated Hermes, Inc. and affiliated entities filed an amended Schedule 13G disclosing their beneficial ownership position in aTyr Pharma, Inc. as passive investors. The filing identifies the reporting persons as investment advisers, parent holding companies, and trustees, who disclaim beneficial ownership beyond their advisory roles.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ATYR stock react to this filing?
ATYR closed at $11.34 before the filing and $11.13 on Oct 7, 2026 (-1.80%). Five trading days later: $8.04 (-29.04%).
Other ATYR SEC filings
- 10-Q · SEC filingNov 6, 2026
- 8-K · Shelf registrationNov 6, 2026
- 424B5 · Shelf registrationNov 6, 2026
- 8-K · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingNov 4, 2026
- 8-K · Stock splitOct 27, 2026
- 8-K · Stock splitOct 16, 2026
- 8-K · Fda approvalSep 24, 2026
- DEF 14A · Stock splitSep 11, 2026
- 10-Q · SEC filingAug 7, 2026
Get alerts when ATYR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days